Related Experiment Video
Updated: Aug 11, 2026

A Novel Method: Super-selective Adrenal Venous Sampling
Published on: September 15, 2017
Bilateral Adrenal Hemorrhage in Coronavirus Disease 2019 Patient: A Case Report
Meir Frankel1, Itamar Feldman2, Michal Levine3
1Endocrinology Unit, Shaare Zedek Medical Center, Jerusalem, Israel.
Insights
Bilateral adrenal hemorrhage, a rare cause of adrenal insufficiency, can be triggered by COVID-19 infection. Early adrenal axis testing is vital for prompt diagnosis and treatment in at-risk patients.
Area of Science:
- Endocrinology
- Infectious Diseases
- Hematology
Background:
- Bilateral adrenal hemorrhage (BAH) is a rare condition with severe consequences, including acute adrenal insufficiency.
- Coronavirus disease 2019 (COVID-19) is known to cause coagulopathy and thromboembolic events.
- Early diagnosis and treatment through adrenal axis testing and imaging are critical.
Observation:
- A 66-year-old woman with a history of antiphospholipid syndrome (APLS) presented with acute COVID-19 infection, BAH, and renal vein thrombosis.
- Despite resolving COVID-19 symptoms, she required ongoing glucocorticoid and mineralocorticoid replacement therapy.
- The patient's condition suggests a 'two-hit' mechanism involving APLS and COVID-19 contributing to the adrenal event.
Findings:
- COVID-19 infection is linked to thromboembolic events, including BAH.
- Adrenal insufficiency resulting from BAH is a life-threatening condition.
- The case highlights a potential synergistic effect of APLS and COVID-19 in causing BAH.
Implications:
- Adrenal insufficiency necessitates prompt recognition and management.
- Early adrenal axis testing should be considered in COVID-19 patients presenting with symptoms suggestive of adrenal insufficiency.
- Understanding the interplay between viral infections and pre-existing prothrombotic conditions is crucial for patient care.
Context:
Bilateral adrenal hemorrhage is a rare condition with potentially life-threatening consequences such as acute adrenal insufficiency. Early adrenal axis testing, as well as directed imaging, is crucial for immediate diagnosis and treatment. Coronavirus disease 2019 (COVID-19) has been associated with coagulopathy and thromboembolic events.
Case Description:
A 66-year-old woman presented with acute COVID-19 infection and primary adrenal insufficiency due to bilateral adrenal hemorrhage (BAH). She also had a renal vein thrombosis. Her past medical history revealed primary antiphospholipid syndrome (APLS). Four weeks after discharge she had no signs of COVID-19 infection and her polymerase chain reaction test for COVID-19 was negative, but she still needed glucocorticoid and mineralocorticoid replacement therapy. The combination of APLS and COVID-19 was probably responsible of the adrenal event as a "two-hit" mechanism.
Conclusions:
COVID-19 infection is associated with coagulopathy and thromboembolic events, including BAH. Adrenal insufficiency is life threatening; therefore, we suggest that early adrenal axis testing for COVID-19 patients with clinical suspicion of adrenal insufficiency should be carried out.
Related Concept Videos
Adrenal Gland Disorders
Adrenal insufficiency, characterized by insufficient cortisol and aldosterone production, leads to conditions like Addison's disease. This disorder, affecting the adrenal cortex, exhibits symptoms such as skin bronzing, dehydration, low blood pressure, fatigue, and weight loss. Congenital adrenal hyperplasia, a genetic ailment causing...
Acute Respiratory Failure-I
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
Acute Respiratory Failure-II
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
Acute Respiratory Failure-III
Acute Respiratory Failure-V
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Coronavirus
